| Trial ID: | L5311 |
| Source ID: | NCT00612599
|
| Associated Drug: |
Biphasic Insulin Aspart
|
| Title: |
Comparison of Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 50 to Biphasic Insulin Aspart 70 in Type 2 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes|Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: biphasic insulin aspart
|
| Outcome Measures: |
Primary: Area under the serum glucose concentration profile during 24 hours, after 4 weeks of treatment | Secondary: Pharmacodynamics properties|Pharmacokinetic properties|8-point self-monitored blood glucose profiles|Adverse events|Hypoglycaemic episodes
|
| Sponsor/Collaborators: |
Sponsor: Novo Nordisk A/S
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
75
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2003-09
|
| Completion Date: |
2004-06
|
| Results First Posted: |
|
| Last Update Posted: |
2017-01-06
|
| Locations: |
Novo Nordisk Investigational Site, Århus C, 8000, Denmark
|
| URL: |
https://clinicaltrials.gov/show/NCT00612599
|
